Brian McNamee - Amgen Insider

Amgen Inc -- USA Stock  

USD 183.55  0.05  0.0272%

Executive Vice President - Full Potential Initiatives

Mr. Brian M. McNamee is the Executive Vice President Full Potential Initiatives of Amgen Inc. Mr. McNamee joined the Company in June 2001 as Senior Vice President, Human Resources. From November 1999 to June 2001, Mr. McNamee served as Vice President of Human Resources at Dell Computer Corporationration From 1998 to 1999, Mr. McNamee served as Senior Vice President, Human Resources for the National Broadcasting Corporationrationration, a division of the GE. From July 1988 to November 1999, Mr. McNamee held human resources positions at GE.
Age: 59  President Since 2013      

Brian McNamee Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 8.32 % which means that it generated profit of $8.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 7.18 % meaning that it created $7.18 on every $100 dollars invested by stockholders.
The company currently holds 35.34 B in liabilities with Debt to Equity (D/E) ratio of 140.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 5.38 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


Jaime ContrerasAbbott Laboratories
Andrew LaneAbbott Laboratories
Matthew MalettaEndo International plc
Wayne SwantonAllergan plc
Eric FainAbbott Laboratories
Blaise ColemanEndo International plc
Heather MasonAbbott Laboratories
Charles FoltzAbbott Laboratories
Scott WhiteAbbott Laboratories
Ian SmithVertex Pharmaceuticals Incorpor
Murthy SimhambhatlaAbbott Laboratories
Terrance CoughlinEndo International plc
Amit SachdevVertex Pharmaceuticals Incorpor
Roger BirdAbbott Laboratories
Michael CrowleyBio Rad Laboratories Inc
Michael RousseauAbbott Laboratories
Paul SilvaVertex Pharmaceuticals Incorpor
Jared WatkinAbbott Laboratories
Thomas GraneyVertex Pharmaceuticals Incorpor
Michael WarmuthAbbott Laboratories
Robert FordAbbott Laboratories

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 20800 people.Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Alpha Finder Now

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Hide  View All  NextLaunch Alpha Finder
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Wanda Austin, Director
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators